Court upholds fraud conviction of ex-drug company official

03/5/2013 | Bloomberg Businessweek

A panel of the 9th U.S. Circuit Court of Appeals upheld the fraud conviction of Scott Harkonen, former CEO of InterMune, for distributing misleading information about the clinical trial of Actimmune, a drug he publicized as a lung disease treatment. Three judges rejected the free speech arguments of Harkonen, saying fraudulent speech is not protected by the First Amendment.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ